Register | Forgot password?
Switch to Arabic
Saturday, November 28 - 2009

Ascent's Farley sets the spotlight on the growth of investment activity by women on the stock market

  • United Arab Emirates: Tuesday, November 21 - 2006 at 15:42
  • PRESS RELEASE

One trend is clear; more female entrepreneurs are entering the marketplace. With the changing economies of the region, liberalisation and globalisation, more women are entering the business world every day.

Article continues below
  • Peggy Farley, president and CEO of US-based Ascent Capital Management.
    Peggy Farley, president and CEO of US-based Ascent Capital Management.
Taking part in a roundtable discussion during MEED's Middle East Capital Markets 2006 conference, held on 20-21 November 2006 at Jumeirah Emirates Towers Hotel in Dubai, UAE, Peggy Farley, president and CEO of US-based Ascent Capital Management, shed light on the growth of female investment activities on the world's stock markets.

"More women are entering the market every day. There is a clear trend of female entrepreneurs willing to invest more capital in the securities markets, and this trend is also clear in this (Middle East) region," said Farley.

The regional economies are passing through a period of rapid change. Governments are working hard to further liberalise economies, implement political reforms and enhance their capital markets. On the other hand, women, with their growing socio-economic role, are becoming a critical player in these markets.

With the region's GDP projected to rise from $600 billion in 2006 to $1,000 billion in 2010, an increase of 75 per cent, the region is enjoying a period of growth and prosperity unprecedented in its recent history.

"Regional economies are changing rapidly, thus there is a clear change in the role women traditionally play. With enticing capital markets and growing wealth among families and businesses, it is becoming clear that women are grabbing the opportunities that become available,"


added Farley.

Surveys predict a bright economic outlook for the region. But, according to Farley, the region is facing many challenges within its socio-economic framework that need to be dealt with correctly.

"Although there are great challenges, the market should take a closer look at the growing role of women for further development, thus leading to more enhanced and stronger stock markets.

"Nurturing the domestic capital markets can be achieved by encouraging more women into entering these markets and investing their wealth efficiently," highlighted Farley.

"Women can play a critical role in developing the economies; this trend is true as we are having more listed companies run by women, many more women-only events, and more female entrepreneurs. Moreover, women in the US play a very important role in the medical industry, and we should be able to see this in the Middle East where women can play a bigger role in this industry," she ended.

With more than 250 delegates attending the conference, the two-day Middle East Capital Markets 2006 has stirred timely debate on global and regional capital markets by over 51 speakers over 21 sessions.

US-based Ascent Group has launched its $100 million Ascent Medical Technology Fund II, a private equity vehicle aiming to promote the development of the Middle East medical industry. And only recently, it closed on the first deal of this fund.

The Fund invests in US companies that have cutting-edge products and services. It then requires those companies to use 50 per cent or more of the funds to operate or produce their product or service in the Middle East.
Also consider reading:
Log in to request more information from Ascent Group

Notes and media contacts

For further media information, contact:

Euro RSCG Furness for Ascent Technologies
Hisham El Masri
Tel +9714 3903030
Mob +97150 4469242
Fax +9714 3918486

The Ascent Medical Technology Fund II, L.P. (the Fund) is being established by Ascent Private Equity II LLC to make privately negotiated investments in seed, early and mezzanine stage growth companies principally in the medical device industry and, to a lesser extent, in other medical technology industries.
To diversify access to scientific innovation, enhance the profitability of investments, and streamline proof of clinical efficacy, the Fund will be involving certain emerging markets in growing the companies in which the Fund invests.
All Fund investments will avail themselves of opportunities that exist in selected emerging economies for clinical research, manufacturing, and intellectual property. This objective will be achieved either by (1) investing in US companies which will in turn invest in joint ventures or wholly owned subsidiaries located in developing countries; or, (2) by establishing businesses directly in emerging markets.
The Fund is seeking to raise aggregate capital commitments of $100 million. The minimum commitment is $1 million for individual investors and $5 million for institutional investors. A first closing will take place when the Fund has raised a minimum of $30 million of aggregate commitments.

Fund II is a Delaware Limited Partnership. The General Partner, a Delaware Limited Liability Company, has established in Bahrain a Feeder Fund Company that is a Limited Partner of the Fund. The Bahrain Company is for those non-US investors who do not wish to invest directly into the US Fund.

The Principals of the General Partner managed Ascent Medical Technology Fund, L.P. ("Fund I") and Ascent Private Equity, LLC, established, respectively in 2000 and 1999. The advisor to the Fund, Ascent Capital Management Inc., is a US Securities and Exchange Commission Registered Investment Advisory firm. Fund I is more than 75 per cent invested, thus, enabling the principals of the General Partner to develop the Fund. Fund I has seen two harvests. The ROI is in excess of 240 per cent. All of Fund I's other investments are operating; many have seen tremendous success since the time Fund I invested in them.

Disclaimer:

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions